Skip to content
Back
Home
News
Commentary
Video
Podcasts
About
The Washington Times
Federal appeals court rules Education Department wrongly denied Christian school’s nonprofit status
Americans should embrace 4B feminism with gusto
DePaul University ‘outraged’ after two Jewish students attacked by masked assailants
Advertisement
Home
Topics
Novartis
Novartis
Latest Stories
FDA approves first lower-cost biotech drug
By Matthew Perrone
- Associated Press
Shares
Novel heart failure drug shows big promise: study
By Marilynn Marchione
- Associated Press
Shares
When generics win, patients lose
By Peter Pitts
- The Washington Times
Shares
PITTS: When generics win, patients lose
By Peter Pitts
Shares
6 European countries pull Novartis flu vaccines
By ASSOCIATED PRESS
- Associated Press
Shares
Germany orders recall of some Novartis flu shots
By FRANK JORDANS
- Associated Press
Shares
Drug company recalls bottles of Excedrin, NoDoz
By ASSOCIATED PRESS
- Associated Press
Shares
Economy Briefs
By THE WASHINGTON TIMES
Shares
European drugmakers hit with poor test results
By GREG KELLER
- Associated Press
Shares
EU opens antitrust probe into Novartis, J&J
By ASSOCIATED PRESS
- Associated Press
Shares
Novartis gains FDA approval for new MS drug
By MATTHEW PERRONE
- Associated Press
Shares
Previous
1
2
next
Entire Story